Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

FIRST PATIENT WITH BASAL CELL CARCINOMA TREATED IN NEW FOCUSED ULTRASOUND STUDY: TOOsonix A/S

The dermatology departments at Bispebjerg and Roskilde Hospitals, University of Copenhagen, Denmark, initiate pioneering treatment of the world's most common cancer with a new convenient, minimal-pain and easy-to-operate modality for skin oncology. HOERSHOLM, Denmark, April 19, 2022 /PRNewswire...

2022-04-19 21:08 1964

Excelra Makes Strategic Investment in Anlitiks, a Disruptive HEOR and RWE Technology-led Consulting Company

HYDERABAD, India and BOSTON, Mass., April 19, 2022 /PRNewswire/ -- Excelra, a leading global Data and Analytics provider for Life Science organizations, has announced a strategic majority investment in Anlitiks, a young and rapidly growing technology company in the value and evidence domain. The...

2022-04-19 21:00 2632

Mission Bio Partners with S2 Genomics to Offer Robust Solid Tumor Sample Prep for Single-Cell DNA Analysis

MSKCC lab paired Tapestri and Singulator 100 to demonstrate automated nuclei extraction workflow for fast and reliable nuclei prep for single-cell DNA analysis SOUTH SAN FRANCISCO, Calif., April 19, 2022 /PRNewswire/ -- Mission Bio, Inc. , the pioneer in high-throughput single-cell DNA and multi-...

2022-04-19 20:00 1650

SMART Medical Systems' G-EYE® Colonoscope is now FDA Cleared on Olympus' PCF Colonoscope Series, Making it Available in the United States on the Commonly Used Models of All Leading Endoscopy Brands

- FDA has approved the use of G-EYE® with Olympus' 510(k) cleared PCF colonoscopes - RA'ANANA, Israel, April 19, 2022 /PRNewswire/ -- SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, today announced an additional FDA clearance for its G-EYE® Colonoscope...

2022-04-19 20:00 1764

Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan

* Nuvaxovid is the first protein-based COVID-19 vaccine approved for use in adults aged 18 and older inJapan * Approval is first in the world for NVX-CoV2373 that includes both primary and booster vaccination GAITHERSBURG, Md., April 19, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a bi...

2022-04-19 19:15 2211

Gastroenterology: NTC submits marketing authorisation application for KLEERKOL® in EU

MILAN, April 19, 2022 /PRNewswire/ -- NTC Srl, R&D driven pharmaceutical company with headquarters inItaly announces the submission of the marketing authorisation application through the European Decentralised Procedure (DCP) for its development product NTC015 (Kleerkol®) for bowel preparation fo...

2022-04-19 18:00 1736

Ascletis Announces 3CLpro Inhibitor ASC11 Demonstrated Potential to be Effective Treatment for COVID-19

- In antiviral cellular assays, antiviral potency (EC90) of ASC11 is 31-fold of that of Nirmatrelvir, 120-fold of that of S-217622, 16-fold of that of PBI-0451 and 7-fold of that of EDP-235. - ASC11 is an in-house discovered oral small molecule drug candidate, targeting 3CLpro, with global intel...

2022-04-19 16:50 2221

Mediscience Espoir Inc. Looking for OEM Customers, Technical Business Partners and Sales Agents for Oxygen Clathrate Hydrates and Oxygen Solutions

KAWASAKI, Japan, April 19, 2022 /PRNewswire/ -- Mediscience Espoir Inc. announced onApril 19 that it is looking for U.S. partners for oxygen clathrate hydrates and oxygen solutions based on its proprietary technology. The company obtained "Substance Patent" in the United States (US 10,913,037 B2)...

2022-04-19 14:00 1196

Translumina launches VIVO ISAR, its Dual-Drug Polymer-free Coated Stent (DDCS) in International markets

Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey NEW DELHI and HECHINGEN, Germany, April 19, 2022 /PRNewswire/ -- Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used...

2022-04-19 14:00 2142

Pondok Indah Hospital Group first in Indonesia to achieve HIMSS EMRAM Stage 6

JAKARTA, Indonesia, April 19, 2022 /PRNewswire/ -- HIMSS announced today that Pondok Indah Hospital Group has become the first healthcare provider inIndonesia to achieve Stage 6 on the HIMSS Electronic Medical Record Adoption Model (EMRAM). The eight-stage EMRAM measures clinical outcomes, patien...

2022-04-19 13:59 1918

GILEAD SCIENCES AND NATIONAL FOUNDATION OF DIGESTIVE DISEASES SET OUT TO STRENGTHEN LEARNING, ACCESS TO LIVER HEALTH EDUCATION IN SINGAPORE

-- Gilead Sciences supports National Foundation of Digestive Diseases with grant funding to improve liver health education inSingapore as part of its Asia Pacific ALL4LIVER Grant -- -- The National Foundation of Digestive Diseases gets digital upgrade to enhance liver health awareness and educa...

2022-04-19 11:00 1863

Proprietary SARS-CoV-2 3CL Inhibitor Rapidly Progressing in Clinical Trials, Market Approval of Trilaciclib Expected in China, Simcere Reveals Global Innovation Ambition on R&D Day

NANJING, China, April 19, 2022 /PRNewswire/ -- On April 15, 2022, Simcere Pharmaceutical (2096.HK), an innovation and R&D driven pharmaceutical company in China held its first R&D day for international investors, during which the executive leaders revealed Simere's R&D strategy, and gave an update...

2022-04-19 10:28 1821

MGI announces partnership with Nalagenetics to advance pharmacogenomics in Singapore and Indonesia

The partnership will address some critical issues in pharmacogenetic assay through sequencing workflows improvement SINGAPORE, April 19, 2022 /PRNewswire/ -- MGI, a company committed to being a world-leading life science innovator, today announced a partnership with Nalagenetics (NALA) to ...

2022-04-19 10:00 2621

Bridge Biotherapeutics Enters into an Exclusive License Agreement with Shaperon to Strengthen Its IPF Franchise

* The licensing deal includes an upfront payment of USD 1.63 million, and may reach up toUSD 24.4 million in milestone payments and royalties * By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive tre...

2022-04-19 09:19 1553

Prioritizing Quality and Patient Satisfaction, Pondok Indah Hospital Group Achieves HIMSS EMRAM Stage 6, the First in Indonesia

JAKARTA, Indonesia, April 19, 2022 /PRNewswire/ -- Pondok Indah Hospital Group (Rumah Sakit Pondok Indah Group) continues to carry out digital transformation through optimization, efficiency, and continuous integration efforts, consistent with the hospital group commitment to providing the best h...

2022-04-19 09:00 2224

GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate

SUZHOU, China, April 18, 2022 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co., Ltd., a company specializing in site-specific bioconjugation for next generation biotherapeutics, has signed an agreement with a Korean biotech company, Aimed Bio Inc., to co-develop a First-in-Class therapeutic an...

2022-04-19 09:00 1399

BENDIT Technologies Receives U.S. Food and Drug Administration 510(k) Clearance of its Bendit 021" steerable microcatheter

TEL AVIV, Israel, April 19, 2022 /PRNewswire/ -- BENDIT Technologies , a company focused on the development of a steerable microcatheter platform, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bendit21 microcath...

2022-04-19 08:00 1680

Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases

* New data on COVID-19 Influenza combination vaccine and seasonal influenza vaccine to be presented at World Vaccine Congress * Several abstracts and presentations slated to highlight updates on NVX-CoV2373, Novavax' COVID-19 vaccine GAITHERSBURG, Md., April 18, 2022 /PRNewswire/ -- Novavax...

2022-04-18 22:13 2666

WHO report highlights the role of Traditional Chinese Medicine in the treatment of COVID-19

BEIJING, April 18, 2022 /PRNewswire/ -- A news report by haiwainet.cn: On March 31, World Health Organization released the meeting report of "WHO Expert Meeting on Evaluation of Traditional Chinese Medicine (TCM) in the Treatment of COVID-19" on its official website. The report acknowledged that ...

2022-04-18 15:18 1850

Illumina Singapore Jumps the Ranks to Earn Two Significant Spots in Singapore's Best Employers Award

The Annual Singapore's Best Employers survey is sponsored by The Straits Times and marketing firm, Statista. SINGAPORE, April 18, 2022 /PRNewswire/ -- Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) was honoured today to be ranked #17 overall and #1 in Healthcare Equipment & Servic...

2022-04-18 12:00 2621

1 ... 254 255 256257258 259 260 ... 576